Corvus Pharmaceuticals, Inc. Common Stock (CRVS)

$ 5.29
   
  • Change Today:
    $0.10
  • 52 Week High: $9.56
  • 52 Week Low: $2.72
  • Currency: US Dollars
  • Shares Issued: 29.20m
  • Volume: 366,140
  • Market Cap: $154.46m
  • RiskGrade: 454
  • Beta: 0.58

Latest ShareCast News

Corvus Pharmaceuticals leaps after launching phase one trial for Covid-19 treatment

By Alexander Bueso

Date: Tuesday 07 Jul 2020

(Sharecast News) - Stock in US-based Corvus Pharmaceuticals nearly doubled on Tuesday after announcing its plans to launch an early state clinical trial for an experimental monoclonal antibody to treat Covid-19.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CRVS Market Data

Currency US Dollars
Share Price $ 5.29
Change Today $ 0.10
% Change 1.93 %
52 Week High $9.56
52 Week Low $2.72
Volume 366,140
Shares Issued 29.20m
Market Cap $154.46m
Beta 0.58
RiskGrade 454

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 21-Aug-2025

Time Volume / Share Price
16:00 24,910 @ $5.29
15:59 100 @ $5.30
15:59 334 @ $5.30
15:59 100 @ $5.30
15:59 700 @ $5.30

Top of Page